Increased gene copy number of KIT and VE
✍
Ida Johansson; Kristina E. Aaltonen; Anna Ebbesson; Dorthe Grabau; Caroline Wige
📂
Article
📅
2011
🏛
John Wiley and Sons
🌐
English
⚖ 944 KB
## Abstract Triple‐negative breast cancer (TNBC) is associated with poor prognosis and no targeted treatments are available for TNBC. Drugs inhibiting tyrosine kinases, such as vascular endothelial growth factor receptor 2 (VEGFR2) and KIT, have shown some promising results for patients with TNBC.